These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26549849)

  • 41. Establishment of a feeder and serum-free culture system for human embryonic stem cells.
    Wang L; Zhang R; Ma R; Jia G; Jian S; Zeng X; Xiong Z; Li B; Li C; Lv Z; Bai X
    Zygote; 2020 Jun; 28(3):175-182. PubMed ID: 31965957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells.
    Burton P; Adams DR; Abraham A; Allcock RW; Jiang Z; McCahill A; Gilmour J; McAbney J; Kane NM; Baillie GS; McKenzie FR; Baker AH; Houslay MD; Mountford JC; Milligan G
    Biochem Soc Trans; 2010 Aug; 38(4):1058-61. PubMed ID: 20659003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate.
    Stefanovic S; Abboud N; Désilets S; Nury D; Cowan C; Pucéat M
    J Cell Biol; 2009 Sep; 186(5):665-73. PubMed ID: 19736317
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Porcine
    Kim SH; Choi KH; Lee M; Lee DK; Lee CK
    Cell Reprogram; 2021 Jun; 23(3):168-179. PubMed ID: 34037424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defective insulin receptor signaling in hPSCs skews pluripotency and negatively perturbs neural differentiation.
    Teo AKK; Nguyen L; Gupta MK; Lau HH; Loo LSW; Jackson N; Lim CS; Mallard W; Gritsenko MA; Rinn JL; Smith RD; Qian WJ; Kulkarni RN
    J Biol Chem; 2021; 296():100495. PubMed ID: 33667549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. n-Butylidenephthalide (BP) maintains stem cell pluripotency by activating Jak2/Stat3 pathway and increases the efficiency of iPS cells generation.
    Liu SP; Harn HJ; Chien YJ; Chang CH; Hsu CY; Fu RH; Huang YC; Chen SY; Shyu WC; Lin SZ
    PLoS One; 2012; 7(9):e44024. PubMed ID: 22970157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. iTRAQ proteome analysis reflects a progressed differentiation state of epiblast derived versus inner cell mass derived murine embryonic stem cells.
    Fröhlich T; Kösters M; Graf A; Wolf E; Kobolak J; Brochard V; Dinnyés A; Jouneau A; Arnold GJ
    J Proteomics; 2013 Sep; 90():38-51. PubMed ID: 23603003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlations between the levels of Oct4 and Nanog as a signature for naïve pluripotency in mouse embryonic stem cells.
    Muñoz Descalzo S; Rué P; Garcia-Ojalvo J; Martinez Arias A
    Stem Cells; 2012 Dec; 30(12):2683-91. PubMed ID: 22969005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maintenance of active chromatin states by HMGN2 is required for stem cell identity in a pluripotent stem cell model.
    Garza-Manero S; Sindi AAA; Mohan G; Rehbini O; Jeantet VHM; Bailo M; Latif FA; West MP; Gurden R; Finlayson L; Svambaryte S; West AG; West KL
    Epigenetics Chromatin; 2019 Dec; 12(1):73. PubMed ID: 31831052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A unique Oct4 interface is crucial for reprogramming to pluripotency.
    Esch D; Vahokoski J; Groves MR; Pogenberg V; Cojocaru V; Vom Bruch H; Han D; Drexler HC; Araúzo-Bravo MJ; Ng CK; Jauch R; Wilmanns M; Schöler HR
    Nat Cell Biol; 2013 Mar; 15(3):295-301. PubMed ID: 23376973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nac1 facilitates pluripotency gene activation for establishing somatic cell reprogramming.
    Choi H; Park HJ; Kim H; Kim J; Lee YK; Kim J
    Biochem Biophys Res Commun; 2019 Oct; 518(2):253-258. PubMed ID: 31412978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. And then there were none: no need for pluripotency factors to induce reprogramming.
    Chou BK; Cheng L
    Cell Stem Cell; 2013 Sep; 13(3):261-2. PubMed ID: 24012365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medaka Oct4 is essential for pluripotency in blastula formation and ES cell derivation.
    Liu R; Li M; Li Z; Hong N; Xu H; Hong Y
    Stem Cell Rev Rep; 2015 Feb; 11(1):11-23. PubMed ID: 25142379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small-Molecule Induction of Canine Embryonic Stem Cells Toward Naïve Pluripotency.
    Tobias IC; Brooks CR; Teichroeb JH; Villagómez DA; Hess DA; Séguin CA; Betts DH
    Stem Cells Dev; 2016 Aug; 25(16):1208-22. PubMed ID: 27392793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of small molecules that promote human embryonic stem cell self-renewal.
    Kumagai H; Suemori H; Uesugi M; Nakatsuji N; Kawase E
    Biochem Biophys Res Commun; 2013 May; 434(4):710-6. PubMed ID: 23541943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OCT4 Acts as an Integrator of Pluripotency and Signal-Induced Differentiation.
    Simandi Z; Horvath A; Wright LC; Cuaranta-Monroy I; De Luca I; Karolyi K; Sauer S; Deleuze JF; Gudas LJ; Cowley SM; Nagy L
    Mol Cell; 2016 Aug; 63(4):647-661. PubMed ID: 27499297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zic3 is required for maintenance of pluripotency in embryonic stem cells.
    Lim LS; Loh YH; Zhang W; Li Y; Chen X; Wang Y; Bakre M; Ng HH; Stanton LW
    Mol Biol Cell; 2007 Apr; 18(4):1348-58. PubMed ID: 17267691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. INO80 facilitates pluripotency gene activation in embryonic stem cell self-renewal, reprogramming, and blastocyst development.
    Wang L; Du Y; Ward JM; Shimbo T; Lackford B; Zheng X; Miao YL; Zhou B; Han L; Fargo DC; Jothi R; Williams CJ; Wade PA; Hu G
    Cell Stem Cell; 2014 May; 14(5):575-91. PubMed ID: 24792115
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional roles of pluripotency transcription factors in mesenchymal stem cells.
    Tsai CC; Hung SC
    Cell Cycle; 2012 Oct; 11(20):3711-2. PubMed ID: 22951581
    [No Abstract]   [Full Text] [Related]  

  • 60. The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
    Chen Y; Meng L; Yu Q; Dong D; Tan G; Huang X; Tan Y
    Exp Cell Res; 2015 Jan; 330(2):442-450. PubMed ID: 25447206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.